PFO
MD icon

Pathstone Family Office’s Pediatrix Medical MD Stock Holding History

Pathstone Family Office’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7
Closed – – 1058
2020
Q4 		$0 Hold
7
– – ﹤0.01% 1258
2020
Q3 		$0 Sell
7
-7
-50% -$130 ﹤0.01% 915
2020
Q2 		$0 Buy
+14
New +$208 ﹤0.01% 871

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Pathstone Family Office's MD Position: Q1 2021 in Review

Pathstone Family Office sold out of Pediatrix Medical (MD) in Q1 2021, closing a stake of 7 shares.

Pathstone Family Office first reported a position in MD in Q2 2020 and held it in 3 quarters. The position peaked at $0 in Q4 2020. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.

  • Pathstone Family Office reported no remaining Pediatrix Medical position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 7 Pediatrix Medical shares in Q1 2021.
  • Pathstone Family Office first reported a position in Pediatrix Medical in Q2 2020 and held it in 3 quarters.
  • Pathstone Family Office's Pediatrix Medical position peaked at $0 in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.